Selected article for: "account funding and economic costing introduction"
Author: Head, Michael G; Fitchett, Joseph R; Cooke, Mary K; Wurie, Fatima B; Hayward, Andrew C; Lipman, Marc C; Atun, Rifat
Title: Investments in respiratory infectious disease research 1997–2010: a systematic analysis of UK funding
  • Document date: 2014_3_26
    • ID: kbzh3trr_26
    Snippet: • Categorising is subjective, and we do not take into account funding of overheads or the impact of the introduction of full economic costing. Globally an estimated 500,000 deaths annually are attributable to influenza. 5 There was limited funding for pneumococcal and pneumonia research. Whilst infections such as meningitis may be in decline in some countries due to successful introduction of new vaccines, 22 there are still many areas globally.....
    Document: • Categorising is subjective, and we do not take into account funding of overheads or the impact of the introduction of full economic costing. Globally an estimated 500,000 deaths annually are attributable to influenza. 5 There was limited funding for pneumococcal and pneumonia research. Whilst infections such as meningitis may be in decline in some countries due to successful introduction of new vaccines, 22 there are still many areas globally with weak health systems where pneumococcal incidence is high.

    Search related documents:
    Co phrase search for related documents
    • account funding and economic costing introduction: 1
    • account funding and economic costing introduction impact: 1
    • country decline and health system: 1
    • economic costing and health system: 1, 2
    • economic costing and new vaccine: 1, 2
    • economic costing introduction and health system: 1, 2
    • economic costing introduction and new vaccine: 1, 2
    • economic costing introduction impact and health system: 1, 2
    • economic costing introduction impact and new vaccine: 1, 2
    • estimate death and health system: 1, 2, 3, 4, 5, 6, 7, 8
    • estimate death and meningitis infection: 1
    • health system and new vaccine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • health system and pneumococcal incidence: 1
    • health system and successful introduction: 1
    • new vaccine and successful introduction: 1
    • pneumococcal incidence and successful introduction: 1, 2
    • pneumonia pneumococcal research and successful introduction: 1, 2